Cresco Labs (CRLBF) Capital Expenditures (2020 - 2026)

Cresco Labs has reported Capital Expenditures for 7 years, with the latest figure at -$7.6 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 31.28% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$1.7 million (up 72.02% YoY), and the FY2025 full-year result was $97000.0, down 80.2% from the prior year.
• Capital Expenditures for Q1 2026 stood at -$7.6 million, down from $26.2 million in the prior quarter.
• The five-year high for Capital Expenditures was $152.9 million in Q4 2022, with the low at -$39.8 million in Q2 2023.
• Historically, Capital Expenditures has averaged $7.7 million across 5 years, with a median of -$7.2 million in 2025.
• Annual changes were most pronounced in 2023 — Capital Expenditures soared 104.65% — and 2025, when it slumped 800.96%.
• Cresco Labs' Capital Expenditures stood at $152.9 million in 2022, then plunged by 30.71% to $106.0 million in 2023, then slumped by 84.16% to $16.8 million in 2024, then soared by 56.27% to $26.2 million in 2025, then slumped by 129.13% to -$7.6 million in 2026.
• The last three Capital Expenditures figures came in at -$7.6 million (Q1 2026), $26.2 million (Q4 2025), and -$7.2 million (Q3 2025), per Business Quant data.